Abbott India

Abbott India shares surge 3% as net profit jumps 16% YoY to Rs 360.8 crore in Q3

Stock Market Update, January 7: Apollo Hospitals, Apar Industries, Abbott India, Amber Enterprises and more hit 52-week highs today

Abbott India launches 14-Valent Pneumococcal Conjugate vaccine offering broad protection for children

The PneumoShield 14 vaccine protects against 14 different strains of pneumococcal bacteria, exceeding the coverage of PCV-10 and PCV-13 vaccines currently available in India.

Abbott India shares fall nearly 4% following Q2 results 

Abbott India Q2 FY25 Results: Revenue up 9.3% YoY to ₹1,632.67 crore, Net Profit rises 14.6% YoY

Abbott India partners with Takeda Pharmaceuticals to launch Vonefi

Abbott India Limited has announced the signing of a non-exclusive patent license agreement with Takeda Pharmaceuticals Company Limited to market and distribute Vonoprazan in India under the brand name "Vonefi."